Pharmolix
Latest round
- Angel
Last raised
- Aug 2024
Total raised
- $14M
Investors
- 4
About Pharmolix
Established in 2023 and based in Beijing, China, Pharmolix operates as a biopharmaceutical company that focused on the development and application of large models for the biopharmaceutical vertical. The company was incubated by Tsinghua University's Academy of Intelligent Industry Research (AIR). Dr.D.S. in Statistics from Pennsylvania State University in 2012, and was the research leader of the Artificial Intelligence Platform Division at IBM Research - Almaden. The company's self-developed prototype of ChatDD (Chat Drug Design), a conversational biopharmaceutical R&D assistant, is equipped with the capabilities of natural interaction, intelligent inspiration and tool invocation. Its products will serve all aspects of drug development, including early research projects, target discovery, molecular design optimization, clinical trial design, and drug repositioning. The company generates revenue by providing basic model base for the biomedical vertical industry and conversational biomedical research and development assistant.
Who invested in Pharmolix
4 investors across 2 rounds
See all investors in Pharmolix
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Pharmolix
Who invested in Pharmolix?
Pharmolix has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Pharmolix raised?
Pharmolix has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Pharmolix last raise money?
Pharmolix's most recent round on record is a Angel, in Aug 2024.
What does Pharmolix do?
Established in 2023 and based in Beijing, China, Pharmolix operates as a biopharmaceutical company that focused on the development and application of large models for the biopharmaceutical vertical.
Where is Pharmolix headquartered?
Pharmolix is headquartered in Shenzhen, China.
Which VCs invest in companies like Pharmolix?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at Pharmolix's stage. Their profiles are linked below.
VCs backing biotechnology startups at Angel
Raising like Pharmolix? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.